Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interleukin-6 Inhibition”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT06238024
What this trial is testing

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

Who this might be right for
Interleukin-6Ischemic StrokeEndovascular Treatment
Suzhou Municipal Hospital of Anhui Province 108
Post-approval studies (Phase 4)Ended earlyNCT02253394
What this trial is testing

The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study

Who this might be right for
Pulmonary Arterial Hypertension
Brigham and Women's Hospital 2
Not applicableUnknownNCT05867524
What this trial is testing

Characterization of Natural IL-6 Inhibition in Healthy Individuals

Who this might be right for
AutoantibodiesInterleukin-6
University of Copenhagen 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06447701
What this trial is testing

Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

Who this might be right for
Brain DiseasesIschemic StrokeIschemia+4 more
Zhujiang Hospital 486
Post-approval studies (Phase 4)Study completedNCT00978757
What this trial is testing

The Effect of Ketamine on Interleukin-6 Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion

Who this might be right for
Hepatectomy
Hospital Italiano de Buenos Aires 42
Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing

Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120
Testing effectiveness (Phase 2)Study completedNCT04626505
What this trial is testing

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.

Who this might be right for
Chronic Kidney DiseaseInflammationCardiovascular Risk
Novo Nordisk A/S 36
Not applicableStudy completedNCT04616235
What this trial is testing

Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

Who this might be right for
Interleukin-6 InhibitionPhysical StressAppetitive Behavior
Rigshospitalet, Denmark 30
Not applicableUnknownNCT03288584
What this trial is testing

Effects of Interleukin-6 Inhibition on Vascular, Endothelial and Left Ventricular Function in Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisInflammation
University of Athens 60
Large-scale testing (Phase 3)Study completedNCT05407597
What this trial is testing

Inhibition of Bradykinin in COVID-19 Infection With Icatibant

Who this might be right for
SARS CoV 2 Infection
Belfast Health and Social Care Trust 32
Not applicableLooking for participantsNCT07801638
What this trial is testing

Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
Capital Medical University 80
Testing effectiveness (Phase 2)Study completedNCT03863015
What this trial is testing

IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest

Who this might be right for
Heart ArrestOut-Of-Hospital Cardiac ArrestSystemic Inflammatory Response Syndrome
Christian Hassager 80